WHO Expert Committee on Specifications for Pharmaceutical Preparations - WHO Technical Report Series, No. 863 - Thirty-fourth Report
(1996; 200 pages) Voir le document au format PDF
Table des matières
Afficher le document1. Introduction
Ouvrir ce répertoire et afficher son contenu2. The international pharmacopoeia and related activities
Afficher le document3. Simple test methodology
Ouvrir ce répertoire et afficher son contenu4. Stability of dosage forms
Ouvrir ce répertoire et afficher son contenu5. Good manufacturing practices for pharmaceutical products
Ouvrir ce répertoire et afficher son contenu6. Legal and administrative aspects of the functioning of national drug regulatory authorities
Ouvrir ce répertoire et afficher son contenu7. Quality assurance in the supply system
Afficher le document8. Terminology
Afficher le documentAcknowledgements
Afficher le documentReferences
Fermer ce répertoireAnnex 1 - Guidelines for the graphic representation of chemical formulae
Afficher le document1. Introduction
Afficher le document2. Acyclic structures
Afficher le document3. Cyclic structures
Afficher le document4. Ionic structures
Afficher le document5. Isotopically modified compounds
Afficher le document6. Coordination compounds
Afficher le document7. Stereochemistry
Afficher le document8. Carbohydrates
Afficher le document9. Steroids
Afficher le document10. Terpenoids
Afficher le document11. Prostanoids
Afficher le document12. Alkaloids
Afficher le document13. Antibiotics
Afficher le document14. Polypeptides
Afficher le document15. Polymers
Afficher le documentAcknowledgements
Afficher le documentReferences
Afficher le documentAnnex 2 - List of available International Chemical Reference Substances1
Afficher le documentAnnex 3 - List of available International Infrared Reference Spectra
Ouvrir ce répertoire et afficher son contenuAnnex 4 - General recommendations for the preparation and use of infrared spectra in pharmaceutical analysis
Ouvrir ce répertoire et afficher son contenuAnnex 5 - Guidelines for stability testing of pharmaceutical products containing well established drug substances in conventional dosage forms
Ouvrir ce répertoire et afficher son contenuAnnex 6 - Good manufacturing practices: guidelines on the validation of manufacturing processes
Ouvrir ce répertoire et afficher son contenuAnnex 7 - Good manufacturing practices: supplementary guidelines for the manufacture of investigational pharmaceutical products for clinical trials in humans
Ouvrir ce répertoire et afficher son contenuAnnex 8 - Good manufacturing practices: supplementary guidelines for the manufacture of herbal medicinal products1
Ouvrir ce répertoire et afficher son contenuAnnex 9 - Multisource (generic) pharmaceutical products: guidelines on registration requirements to establish interchangeability
Ouvrir ce répertoire et afficher son contenuAnnex 10 - Guidelines for implementation of the WHO Certification Scheme on the Quality of Pharmaceutical Products Moving in International Commerce
Ouvrir ce répertoire et afficher son contenuAnnex 11 - Guidelines for the assessment of herbal medicines1,2
Ouvrir ce répertoire et afficher son contenuAnnex 12 - Guidelines on import procedures for pharmaceutical products
Afficher le documentBack Cover
 

7. Stereochemistry

7.1 As already mentioned, a broken line denotes a bond projecting behind the plane of the paper and a filled wedge one projecting in front of that plane. A line of normal thickness denotes a bond lying in the plane of the paper. Hatched lines are sometimes used instead of broken lines. The practice of using a reversed wedge instead of a broken line for a bond projecting behind the plane of the paper is not recommended. In complicated structures, the dashes can be lengthened, shortened or displaced if necessary.

7.2 Hydrogen is represented by its symbol "H" whenever a configuration has to be shown.

Geometric isomerism

7.3 For compounds containing double bonds it is customary to draw the formula so that the reference plane of the double bond is perpendicular to that of the paper; the bonds whereby atoms are attached directly to the doubly bonded atoms lie in the plane of the paper and are depicted with lines of normal thickness.

7.4 Isomers are shown with the two sequence-rule-preferred atoms or groups (each attached to one atom of the double bond) placed on the same side of the reference plane for the (Z)-isomer and on the opposite side of this for the (E)-isomer:

7.5 In simplified carbon chains depicted by lines at an angle to one another, the hydrogen, if any, may be omitted (see sections 10 and 11):

Examples of (Z)-compounds:

Examples of (E)-compounds:

(Note that the two bonds attached to the carbons of the triple bond are drawn in a straight line.)

7.6 The same conventions are used for the isomers of oximes:

7.7 If the stereochemistry relative to the double bond is not specified a linear representation may be useful:

7.8 The same conventions are used for compounds with several double bonds:

Compounds with one centre of asymmetry

7.9 In acyclic compounds with one centre of asymmetry, the general conventions can be used to represent each isomer either as a linear structure or with lines at an angle to each other (if possible, the larger "condensed" groups should be on the right, for aesthetic reasons).

(International Nonproprietary Names apply, by definition, to the L-form.)

7.10 The racemate can be represented by showing both isomers side by side or, more simply, showing only the (R)-isomer followed by the legend "and enantiomer".

7.11 Similar representations are used for cyclic compounds with one centre of asymmetry:

(International Nonproprietary Names apply, by definition, to the L-form.)

7.12 If the chirality of the centre is unknown or not specified, the bonds joining atoms or groups to the chiral atom are shown as lines of "normal" thickness. The use of a star or asterisk to identify the chiral centre may be useful:

Compounds with several chiral centres

7.13 In compounds containing several centres of asymmetry, the same conventions apply to each of these centres:

7.14 The racemates (racephedrine and racementhol respectively) are depicted by the same structures followed by the legend "and enantiomer", rather than by showing the two isomers side by side.

7.15 The same conventions are used for cis-trans isomerism relative to a planar (or approximately planar) ring:

7.16 Mixtures of epimers are often shown by using the "normal" dashes at the epimeric centre (see also section 11):

However, the substance is preferably represented by showing the (R)-isomer at the epimeric centre, placing an asterisk near this C atom and adding the legend "and epimer at C*":

7.17 In more complicated cases, it is better to draw each component of the mixture so as to show all the pecularities of the structure:

Isomerism of fused rings

7.18 In polycyclic compounds, the atoms or groups attached at saturated bridgeheads common to two rings are shown by their symbols so as to indicate the stereochemistry resulting from the way that the cycles are fused.

The cis-isomer is depicted with the bonds shown either both as wedges or both as broken lines:

The trans-isomer is depicted with one of the bonds as a wedge and the other as a broken line:

vers la section précédente vers la section suivante
 

Dernière mise à jour: le 3 mai 2013